| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
54,822 |
49,642 |
$2.78M |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
43,294 |
41,690 |
$1.77M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,950 |
13,058 |
$937K |
| X5622 |
|
15,923 |
15,296 |
$893K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,076 |
8,800 |
$489K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19,389 |
18,788 |
$482K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,422 |
7,250 |
$384K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,653 |
7,245 |
$342K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,641 |
5,337 |
$285K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
8,100 |
7,849 |
$233K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,662 |
3,562 |
$191K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
895 |
876 |
$120K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
24,030 |
19,820 |
$101K |
| 99188 |
|
15,821 |
15,387 |
$96K |
| 90461 |
|
8,718 |
8,494 |
$95K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,988 |
3,818 |
$92K |
| 92551 |
|
18,734 |
18,210 |
$87K |
| 0240U |
|
601 |
588 |
$84K |
| 96127 |
|
19,582 |
18,198 |
$76K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
10,235 |
9,805 |
$73K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
678 |
651 |
$69K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
532 |
522 |
$38K |
| 83655 |
|
2,569 |
2,503 |
$27K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
275 |
271 |
$25K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,455 |
4,242 |
$24K |
| 36416 |
|
8,825 |
8,288 |
$23K |
| 99173 |
|
20,140 |
19,602 |
$18K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
464 |
447 |
$12K |
| 80061 |
Lipid panel |
1,149 |
1,120 |
$11K |
| 90686 |
|
12,153 |
11,830 |
$11K |
| 0071A |
|
275 |
272 |
$10K |
| 0072A |
|
252 |
250 |
$10K |
| 87634 |
|
141 |
140 |
$10K |
| 90651 |
|
1,686 |
1,655 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,100 |
1,053 |
$7K |
| 96161 |
|
4,883 |
4,654 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
402 |
381 |
$4K |
| 85018 |
|
2,052 |
2,002 |
$4K |
| 99460 |
|
87 |
85 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
41 |
40 |
$3K |
| 90480 |
|
168 |
158 |
$3K |
| 90834 |
Psychotherapy, 45 minutes with patient |
50 |
41 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
150 |
145 |
$3K |
| 90620 |
|
302 |
296 |
$3K |
| 0001A |
|
115 |
114 |
$3K |
| 0002A |
|
113 |
113 |
$2K |
| 90734 |
|
1,206 |
1,178 |
$2K |
| 90474 |
|
824 |
769 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
296 |
291 |
$2K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
46 |
46 |
$2K |
| 90715 |
|
727 |
715 |
$1K |
| 99383 |
|
15 |
15 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
475 |
461 |
$1K |
| 90670 |
|
5,555 |
5,379 |
$1K |
| 81003 |
|
446 |
420 |
$674.59 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
124 |
117 |
$641.78 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$488.95 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
14 |
$488.95 |
| 90710 |
|
413 |
404 |
$309.71 |
| 94664 |
|
29 |
29 |
$296.82 |
| 90723 |
|
4,107 |
3,977 |
$286.91 |
| 90681 |
|
1,646 |
1,608 |
$257.71 |
| 90633 |
|
2,791 |
2,709 |
$256.23 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
12 |
$141.85 |
| 90656 |
|
451 |
447 |
$110.94 |
| 82248 |
|
16 |
12 |
$76.86 |
| 90647 |
|
4,163 |
4,030 |
$33.63 |
| 90672 |
|
32 |
31 |
$29.13 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
36 |
36 |
$11.93 |
| 90696 |
|
627 |
617 |
$11.79 |
| 96160 |
|
15,109 |
14,591 |
$7.96 |
| 90716 |
|
959 |
938 |
$1.81 |
| 90700 |
|
701 |
689 |
$1.11 |
| 90707 |
|
662 |
646 |
$1.03 |
| 90677 |
|
52 |
49 |
$0.11 |
| 91321 |
|
38 |
35 |
$0.10 |
| 90680 |
|
232 |
199 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
14 |
14 |
$0.00 |
| 99381 |
|
14 |
13 |
$0.00 |
| 91300 |
|
103 |
100 |
$0.00 |